ASKER — Asker Healthcare AB Share Price
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | n/a |
Financial Summary
Year End null | Unit | null | null | null | null | null | nullE | nullE | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | SEKm | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Asker Healthcare Group AB is a Sweden-based primarily engaged in the healthcare industry. The Company focuses on providing medical products and solutions to caregivers and patients across Europe. Vision of Asker Healthcare Group AB is to be the healthcare group in Europe within medical products and solutions, by building and acquiring companies that together with healthcare providers and patients create better health for all. To achieve this vision, the Company has adopted a twin engine growth strategy that combines organic and acquired growth. Asker Healthcare Group AB continuously acquires small and medium-sized companies that complement its existing business. The companies acquired brings a wider product range, new geographies, customer segments or channels to the Group.
Directors
- Last Annual
- Last Interim
- Incorporated
- December 11th, 2018
- Public Since
- March 27th, 2025
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
OMX Nordic Exchange Stockholm

- Address
- Svardvagen 3A, DANDERYD, 182 33
- Web
- https://www.asker.com/
- Phone
- +46 855601100
- Auditors
Similar to ASKER
Acarix AB
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
As of Today at 19:23 UTC, shares in Asker Healthcare AB are trading at SEK97.11. This share price information is delayed by 15 minutes.
Shares in Asker Healthcare AB last closed at SEK97.11 and the price had moved by over the past 365 days. In terms of relative price strength the Asker Healthcare AB share price has matched the FTSE Global All Cap Index by over the past year.
There is no consensus recommendation for this security.
Find out moreAsker Healthcare AB does not currently pay a dividend.
Asker Healthcare AB does not currently pay a dividend.
Asker Healthcare AB does not currently pay a dividend.
To buy shares in Asker Healthcare AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK97.11, shares in Asker Healthcare AB had a market capitalisation of .
Here are the trading details for Asker Healthcare AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: ASKER
Based on an overall assessment of its quality, value and momentum Asker Healthcare AB is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Asker Healthcare AB. Over the past six months, its share price has matched the FTSE Global All Cap Index by .
As of the last closing price of SEK97.11, shares in Asker Healthcare AB were trading +16.88% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Asker Healthcare AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK97.11.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Asker Healthcare AB's directors